Research
Promising findings for the effective treatment of patients with Pulmonary Arterial Hypertension with a high risk of mortality
… at Université Paris-Saclay, head of the Pneumology Department at Bicêtre Hospital (AP-HP), director of the … A previous phase 3 trial (which allowed for a potential market launch to be considered)1 had already produced positive … just demonstrated the efficacy of sotatercept, a drug marketed by Merck, in significantly reducing the risk of death, …Published on: Wed 16/04/2025 - 07:44